» Articles » PMID: 36272057

Clinical Study of Transcranial Sonography Image Characteristics in Patients with Obstructive Sleep Apnea

Overview
Journal Sleep Breath
Publisher Springer
Date 2022 Oct 22
PMID 36272057
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: This study aimed to explore the relationship between patients with obstructive sleep apnea (OSA) from subgroups of varying severity and substantia nigra (SN) hyperechogenicity as well as cerebral blood flow detected by transcranial sonography (TCS). The study also explored if there were differences in damage of the SN and in the cerebral blood flow between the bilateral sides.

Methods: Right-handed men diagnosed with OSA by polysomnography were recruited from August 2018 to August 2020. The included patients were divided into 3 subgroups (mild, moderate, and severe OSA), and all patients underwent TCS.

Results: Among the 157 study patients (30 with mild OSA, 25 moderate, and 102 severe), the overall prevalence of SN hyperechogenicity was 15% (23/157). The hyperechogenicity detection rates were 3% (4/157) in the right SN subgroup and 13% (20/157) in the left SN subgroup, which were significantly different. The left side always had reduced blood flow on TCS (P < 0.05). No correlation was observed between the severity of OSA and the detection rates of SN hyperechogenicity (P > 0.05).

Conclusion: Patients with OSA showed a higher detection rate of SN hyperechogenicity on the left compared with the right side. The left middle cerebral arteries had reduced blood flow, which was consistent with the more severe damage of the left SN. No relationship was observed between the severity of OSA and the detection rate of SN hyperechogenicity or hemodynamic parameters.

References
1.
Lavie L . Oxidative stress in obstructive sleep apnea and intermittent hypoxia--revisited--the bad ugly and good: implications to the heart and brain. Sleep Med Rev. 2014; 20:27-45. DOI: 10.1016/j.smrv.2014.07.003. View

2.
Guo J, Zhao X, Li Y, Li G, Liu X . Damage to dopaminergic neurons by oxidative stress in Parkinson's disease (Review). Int J Mol Med. 2018; 41(4):1817-1825. DOI: 10.3892/ijmm.2018.3406. View

3.
Berg D, Godau J, Walter U . Transcranial sonography in movement disorders. Lancet Neurol. 2008; 7(11):1044-55. DOI: 10.1016/S1474-4422(08)70239-4. View

4.
Jiang H, Song N, Jiao Q, Shi L, Du X . Iron Pathophysiology in Parkinson Diseases. Adv Exp Med Biol. 2019; 1173:45-66. DOI: 10.1007/978-981-13-9589-5_4. View

5.
Weise D, Lorenz R, Schliesser M, Schirbel A, Reiners K, Classen J . Substantia nigra echogenicity: A structural correlate of functional impairment of the dopaminergic striatal projection in Parkinson's disease. Mov Disord. 2009; 24(11):1669-75. DOI: 10.1002/mds.22665. View